Vanguard S&P Mid-Cap 400 Growth ETF (IVOG)
193.10
-3.19 (-1.63%)
USD |
Jun 18, 20:00
Price Chart
Key Stats
Customize
| Expense Ratio | Discount or Premium to NAV | Total Assets Under Management | 30-Day Average Daily Volume |
|---|---|---|---|
| 0.15% | -0.11% | 902.47M | 6816.87 |
| Dividend Yield | Turnover Ratio | 1 Year Fund Level Flows | Max Drawdown (All) |
| 0.68% | 49.00% | -134.52M | Upgrade |
Basic Info
| Investment Strategy | |
| The investment seeks to track the performance of a benchmark index that measures the investment return of mid-capitalization growth stocks in the United States. The fund employs an indexing investment approach designed to track the performance of the S&P MidCap 400® Growth Index, which represents the growth companies, as determined by the index sponsor, of the S&P MidCap 400 Index. The Advisor attempts to replicate the target index by investing all, or substantially all, of its assets in the stocks that make up the index, holding each stock in approximately the same proportion as its weighting in the index. |
| General | |
| Security Type | Exchange-Traded Fund |
| Equity Style | Mid Cap/Growth |
| Fixed Income Style | -- |
| Broad Asset Class | US Equity |
| Broad Category | Equity |
| Category Name | Mid-Cap Growth |
| Category Index | Russell Mid Cap Growth TR USD |
| Prospectus Objective | Growth and Income |
| Fund Owner Firm Name | Vanguard |
| Prospectus Benchmark Index | |
| S&P MidCap 400 Growth TR USD | 100.0% |
| Broad Asset Class Benchmark Index | |
| ^SPXTR | 100.0% |
| Manager Tenure | |
| William Coleman | 5.47 yrs |
| Awais Khan | 3.50 yrs |
Net Fund Flows Versus Category
1 Month
% Rank:
--
--
Category Low
--
Category High
1 Year
% Rank:
74
-134.52M
-5.040B
Category Low
15.33B
Category High
3 Months
% Rank:
--
--
Category Low
--
Category High
3 Years
% Rank:
--
--
Category Low
--
Category High
6 Months
% Rank:
--
--
Category Low
--
Category High
5 Years
% Rank:
--
--
Category Low
--
Category High
YTD
% Rank:
--
--
Category Low
--
Category High
10 Years
% Rank:
--
--
Category Low
--
Category High
As of May 31, 2021
Performance Versus Category
As of June 18, 2021. Returns for periods of 1 year and above are annualized.
Annual Total Returns Versus Peers
Edit comparables
As of June 18, 2021.
Asset Allocation
Top 10 Holdings
| Name | % Weight | Price | % Change |
|---|---|---|---|
| Bio-Techne Corp | 1.48% | 431.90 | -2.99% |
| Fair Isaac Corp | 1.36% | 502.35 | 0.28% |
| Cognex Corp | 1.29% | 77.67 | -1.70% |
| SolarEdge Technologies Inc | 1.23% | 264.23 | 0.40% |
| Williams-Sonoma Inc | 1.20% | 150.93 | -3.27% |
| Graco Inc | 1.18% | 71.18 | -0.46% |
| FactSet Research Systems Inc | 1.17% | 325.34 | -0.99% |
| Brown & Brown Inc | 1.13% | 51.81 | -1.56% |
| The Toro Co | 1.10% | 104.39 | -0.05% |
| Cree Inc | 1.06% | 91.04 | -2.88% |
News
Headline
Wire
Time (ET)
SA Breaking News
12/21 10:13
SA Breaking News
12/13 05:04
SA Breaking News
12/19 09:58
Basic Info
| Investment Strategy | |
| The investment seeks to track the performance of a benchmark index that measures the investment return of mid-capitalization growth stocks in the United States. The fund employs an indexing investment approach designed to track the performance of the S&P MidCap 400® Growth Index, which represents the growth companies, as determined by the index sponsor, of the S&P MidCap 400 Index. The Advisor attempts to replicate the target index by investing all, or substantially all, of its assets in the stocks that make up the index, holding each stock in approximately the same proportion as its weighting in the index. |
| General | |
| Security Type | Exchange-Traded Fund |
| Equity Style | Mid Cap/Growth |
| Fixed Income Style | -- |
| Broad Asset Class | US Equity |
| Broad Category | Equity |
| Category Name | Mid-Cap Growth |
| Category Index | Russell Mid Cap Growth TR USD |
| Prospectus Objective | Growth and Income |
| Fund Owner Firm Name | Vanguard |
| Prospectus Benchmark Index | |
| S&P MidCap 400 Growth TR USD | 100.0% |
| Broad Asset Class Benchmark Index | |
| ^SPXTR | 100.0% |
| Manager Tenure | |
| William Coleman | 5.47 yrs |
| Awais Khan | 3.50 yrs |
Fundamentals
| General | |
| Distribution Yield | Upgrade |
| Dividend Yield TTM (6-18-21) | 0.68% |
| 30-Day SEC Yield (6-17-21) | Upgrade |
| 7-Day SEC Yield | -- |
| Number of Holdings | Upgrade |
| Stock | |
| Weighted Average PE Ratio | 28.29 |
| Weighted Average Price to Sales Ratio | Upgrade |
| Weighted Average Price to Book Ratio | Upgrade |
| Weighted Median ROE | Upgrade |
| Weighted Median ROA | Upgrade |
| Forecasted Dividend Yield | Upgrade |
| Forecasted PE Ratio | Upgrade |
| Forecasted Price to Sales Ratio | Upgrade |
| Forecasted Price to Book Ratio | Upgrade |
As of May 31, 2021
Growth Estimates
Fund Details
| Key Dates | |
| Inception Date | 9/7/2010 |
| Last Annual Report Date | 8/31/2020 |
| Last Prospectus Date | 12/22/2020 |
| Attributes | |
| Enhanced Index Fund | No |
| Index Fund |
|
| Inverse Fund | No |
| Leveraged Fund | No |
| Fund of Funds | No |
| Currency Hedged Fund | No |
| Synthetic Replication Fund | No |
| Has Dividend Investment Plan | No |
| Socially Responsible Fund | No |
News
Headline
Wire
Time (ET)
SA Breaking News
12/21 10:13
SA Breaking News
12/13 05:04
SA Breaking News
12/19 09:58